Oxonox is set to launch its AirLift and AirStair products this autumn, helping to restore the public’s confidence in post-pandemic hygiene and playing a key part in returning vital industries, such as retail, the built environment and transport infrastructure, back to profit.
Having secured global patent rights for the world’s first use of cold plasma technology, the two new products will provide reassurance to a hygiene-conscious public that busy lifts and escalators are safe in the post-lockdown world.
Using plasma technology, AirLift works by filling the enclosed area with totally germ-free air at a rate of 92 cubic metres per hour. This fresh air dilution process reduces contamination by over 90%, according to independent studies.
AirStair is designed for escalators and moving walkways. It sits underneath the escalator and automatically and permanently sterilises handrails, with up to a 99.999% kill rate, based on laboratory results. It works by directing plasma onto the handrail, killing germs instantly. High-energy bioactive plasma particles permeate and penetrate surfaces for complete coverage, reaching places that disinfectants and ultraviolet light cannot. This is all achieved without the use of chemicals or consumables and prevents regrowth of bacteria and viruses for up to six hours.
www.oxonox.com
Keeping lifts and escalators virus-free
Published 23rd August, 2022 by Neil Nixon